Larimar Therapeutics Inc. (LRMR)
NASDAQ: LRMR
· Real-Time Price · USD
3.69
-0.21 (-5.38%)
At close: Aug 19, 2025, 12:01 PM
-5.38% (1D)
| Bid | 2.86 |
| Market Cap | 315.4M |
| Revenue (ttm) | 241K |
| Net Income (ttm) | -95.23M |
| EPS (ttm) | -1.57 |
| PE Ratio (ttm) | -2.35 |
| Forward PE | -1.94 |
| Analyst | Buy |
| Ask | 4.68 |
| Volume | 780,608 |
| Avg. Volume (20D) | 1,365,675 |
| Open | 3.96 |
| Previous Close | 3.90 |
| Day's Range | 3.65 - 3.99 |
| 52-Week Range | 1.61 - 9.50 |
| Beta | 0.94 |
About LRMR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LRMR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LRMR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-3.02%
Larimar Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
8 months ago
-21.72%
Larimar Therapeutics shares are trading lower after the company reported initial data from its ongoing OLE rare disease drug study.
